- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Acceptability and Long-Term Compliance with Drug Treatment for Hypercholesterolemia in Japanese Male Workers: I. Acceptability of Drug Treatment.
-
- TATEMICHI Masayuki
- Department of Environmental and Occupational Health, Toho University School of Medicine
-
- HAMAGUCHI Tsutahiro
- IBM Japan Medical Services
-
- HASHIRA Munetaka
- Health Management Division of Aizuwakamatsu Factory, Fujitsu Corp.
-
- HAYASHI Takeshi
- Hitachi Health Care Center
-
- ITO Masato
- Health Management Division of Matsushita Electronics Corp.
-
- NAKATANI Atsushi
- Hitachi Health Care Center
-
- HIRO Hisanori
- Center for Occupational Health, Tsurumi, NKK
-
- MORI Koji
- Medicine & Occupational Health, ExxonMobil Business Services Private Ltd.
-
- OOKUBO Yasushi
- Department of Occupational and Environmental Medicine Chiba University School of Medicine
-
- EZAKI Takafumi
- Kyoto Industrial Health Association
-
- SUGIMORI Hiroki
- Department of Preventive Medicine, St. Marianna University School of Medicine
-
- YOSHIDA Katsumi
- Department of Preventive Medicine, St. Marianna University School of Medicine
Bibliographic Information
- Other Title
-
- Acceptability and Long-Term Compliance with Drug Treatment for Hypercholesterolemia in Japanese Male Workers(1)Acceptability of Drug Treatment
- Acceptability and Long‐Term Compliance with Drug Treatment for Hypercholesterolemia in Japanese Male Workers: I. Acceptability of Drug Treatment
- I. Acceptability of Drug Treatment
Search this article
Description
We performed a prospective study to assess the acceptability and long-term compliance with drug treatment for hypercholesterolemia in Japanese male workers aged 40 to 57 yr with hypercholesterolemia detected in legally required periodical physical examinations. This paper describes the acceptability of statin-based drug treatment. All eligible workers who had not improved after 3-month diet therapy were recommended for drug treatment with simvastatin, a 3 hydroxy-3-methylcoenzyme A reductase inhibitor. Subsequently, according to each individual preference, the subjects were divided to two groups: a group which accepted drug treatment (DT) and a group which rejected it. The subjects who did not accept drug treatment were further assigned to two groups according to their preference: a group which accepted only dietary intervention (DI) and a non-treatment group (NT). Among 1,278 workers recruited, 656 (51.3%) were placed in the DT group, 414 (32.4%) in the DI group and 208 (16.3%) in the NT group. In the DT group, mean serum total cholesterol (TC) was the highest [272±30 (SD) mg/dl]. The acceptability of drug treatment was significantly associated with the serum TC level, pre-existing medical history of hypertension and a family history of ischemic heart disease (IHD). The occupational issues such as type of job, overtime worked, sleeping time and psychological status were different among the three groups, and habits of taking breakfast and daily exercise were associated with acceptability of drug treatment. These data suggest that acceptability of the drug treatment is low and associated with the work- and lifestyle- related issues as well as IHD risk factors.
Journal
-
- Journal of Occupational Health
-
Journal of Occupational Health 44 (3), 166-175, 2002
Japan Society for Occupational Health
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679431765888
-
- NII Article ID
- 130004447162
- 110003723213
-
- NII Book ID
- AA11510660
-
- COI
- 1:CAS:528:DC%2BD38XltVOgsLY%3D
-
- ISSN
- 13489585
- 13419145
-
- NDL BIB ID
- 6264208
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed